- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 20-F Annual report (foreign)
- 4.2 Asset Acquisition Agreement
- 4.3 Share Purchase Agreement
- 8.1 List of Subsidiaries
- 12.1 CEO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 12.2 CFO Certification Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 13.1 CEO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 13.2 CFO Certification Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 15.1 Consent of KPMG, Independent Registered Public Accounting Firm
- 15.2 Consent of Pricewaterhousecoopers Zhong Tian Cpas Limited Company
- 99.1 Letter, Dated As of September 30, 2009, from KPMG to the Commission
Exhibit 8.1
List of Our Subsidiaries*
Beijing Yuande Bio-Medical Engineering Co., Ltd., incorporated in the PRC
Beijing GP Medical Technologies Co., Ltd., incorporated in the PRC
Beijing Bio-Ekon Biotechnology Co., Ltd., incorporated in the PRC
CMED Technologies Ltd., incorporated in the British Virgin Islands
CMED Diagnostics Ltd., incorporated in the British Virgin Islands
CMED ECLIA Diagnostic Technology Ltd., incorporated in the British Virgin Islands
Clear Castle Investments Limited, incorporated in the British Virgin Islands
CMED (HK) Limited, incorporated in Hong Kong
CMED Diagnostics (Hong Kong) Limited, incorporated in Hong Kong
CMED ECLIA Diagnostic Technology (Hong Kong) Limited, incorporated in Hong Kong
East Crest Enterprises Limited, incorporated in Hong Kong
* | Our subsidiaries that, in the aggregate, would not be a “significant subsidiary” as defined in rule 1-02(w) of Regulation S-X as of March 31, 2009 are omitted from this list. |